29472953|t|Catechol-O-Methyltransferase (COMT) Gene (Val158Met) and Brain-Derived Neurotropic Factor (BDNF) (Val66Met) Genes Polymorphism in Schizophrenia: A Case-Control Study.
29472953|a|Objective: Several studies have shown that some polymorphisms of genes encoding catechol-O-methyltransferase (COMT), the key enzyme in degrading dopamine, and norepinephrine and the human brain-derived neurotropic factor (BDNF), a nerve growth factor, are strong candidates for risk of schizophrenia (SCZ). In the present study, we aimed at examining the effects of COMT Val158Met (G>A) and BDNF Val66Met (G>A) polymorphisms on SCZ risk in a sample of Iranian population. Method: This case- control study included 92 SCZ patients and 92 healthy controls (HCs). Genotyping of both variants (COMT Val158Met (G>A) and BDNF Val66Met (G>A)) were conducted using Amplification Refractory Mutation System-Polymerase Chain Reaction (ARMS-PCR). Results: The findings revealed that the COMT Val158Met (G>A) polymorphism was not associated with the risk/protective of SCZ in all models (OR=0.630, 95%CI=0.299-1.326, P=0.224, GA vs. GG, OR=1.416, 95%CI=0.719-2.793, P=0.314, AA vs. GG, OR=1.00, 95%CI=0.56-1.79, P=1.00 GA+AA vs. GG, OR=1.667, 95%CI=0.885-3.125, P=0.11, AA vs. GG+GA, OR=1.247, 95%CI=0.825-1.885, P=0.343, A vs. G,). However, BDNF Val66Met (G>A) variant increased the risk of SCZ (OR = 2.008 95%CI = 1.008-4.00, P = 0.047, GA vs. GG, OR = 3.876 95%CI = 1.001-14.925, P = 0.049. AA vs. GG, OR = 2.272. 95%CI = 1.204-4.347, P = 0.011, GA+AA vs. GG, OR = 2.22 95%CI = 1.29-3.82. P = 0.005, A vs. G). Conclusion: The results did not support an association between COMT Val158Met (G>A) variant and risk/protective of SCZ. Moreover, it was found that BDNF Val66Met (G>A) polymorphism may increase the risk of SCZ development. Further studies and different ethnicities are recommended to confirm the findings.
29472953	0	28	Catechol-O-Methyltransferase	Gene	1312
29472953	30	34	COMT	Gene	1312
29472953	42	51	Val158Met	ProteinMutation	tmVar:p|SUB|V|158|M;HGVS:p.V158M;VariantGroup:1;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606;CA#:127287
29472953	57	89	Brain-Derived Neurotropic Factor	Gene	627
29472953	91	95	BDNF	Gene	627
29472953	98	106	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
29472953	130	143	Schizophrenia	Disease	MESH:D012559
29472953	247	275	catechol-O-methyltransferase	Gene	1312
29472953	277	281	COMT	Gene	1312
29472953	312	320	dopamine	Chemical	MESH:D004298
29472953	326	340	norepinephrine	Chemical	MESH:D009638
29472953	349	354	human	Species	9606
29472953	355	387	brain-derived neurotropic factor	Gene	627
29472953	389	393	BDNF	Gene	627
29472953	453	466	schizophrenia	Disease	MESH:D012559
29472953	468	471	SCZ	Disease	MESH:D012559
29472953	533	537	COMT	Gene	1312
29472953	538	547	Val158Met	ProteinMutation	tmVar:p|SUB|V|158|M;HGVS:p.V158M;VariantGroup:1;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606;CA#:127287
29472953	549	552	G>A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:2;CorrespondingGene:627;CorrespondingSpecies:9606
29472953	558	562	BDNF	Gene	627
29472953	563	571	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
29472953	573	576	G>A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:2;CorrespondingGene:627;CorrespondingSpecies:9606
29472953	595	598	SCZ	Disease	MESH:D012559
29472953	684	687	SCZ	Disease	MESH:D012559
29472953	688	696	patients	Species	9606
29472953	757	761	COMT	Gene	1312
29472953	762	771	Val158Met	ProteinMutation	tmVar:p|SUB|V|158|M;HGVS:p.V158M;VariantGroup:1;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606;CA#:127287
29472953	773	776	G>A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:2;CorrespondingGene:627;CorrespondingSpecies:9606
29472953	782	786	BDNF	Gene	627
29472953	787	795	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
29472953	797	800	G>A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:2;CorrespondingGene:627;CorrespondingSpecies:9606
29472953	943	947	COMT	Gene	1312
29472953	948	957	Val158Met	ProteinMutation	tmVar:p|SUB|V|158|M;HGVS:p.V158M;VariantGroup:1;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606;CA#:127287
29472953	959	962	G>A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:2;CorrespondingGene:627;CorrespondingSpecies:9606
29472953	1024	1027	SCZ	Disease	MESH:D012559
29472953	1297	1301	BDNF	Gene	627
29472953	1302	1310	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
29472953	1312	1315	G>A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:2;CorrespondingGene:627;CorrespondingSpecies:9606
29472953	1347	1350	SCZ	Disease	MESH:D012559
29472953	1631	1635	COMT	Gene	1312
29472953	1636	1645	Val158Met	ProteinMutation	tmVar:p|SUB|V|158|M;HGVS:p.V158M;VariantGroup:1;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606;CA#:127287
29472953	1647	1650	G>A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:2;CorrespondingGene:627;CorrespondingSpecies:9606
29472953	1683	1686	SCZ	Disease	MESH:D012559
29472953	1716	1720	BDNF	Gene	627
29472953	1721	1729	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
29472953	1731	1734	G>A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:2;CorrespondingGene:627;CorrespondingSpecies:9606
29472953	1774	1777	SCZ	Disease	MESH:D012559
29472953	Association	MESH:D012559	627
29472953	Association	MESH:D012559	RS#:6265;HGVS:p.V66M;CorrespondingGene:627
29472953	Positive_Correlation	MESH:D009638	MESH:D012559
29472953	Negative_Correlation	MESH:D004298	1312
29472953	Association	MESH:D012559	627

